NCT00253669 Risk Factors for Developing a Blood Clot in Patients Who Are Undergoing Cancer Treatment for Newly Diagnosed Gliomas Status COMPLETED Phase N/A
NCT00253487 Combination Chemotherapy and Radiation Therapy in Treating Younger Patients Who Are Undergoing an Autologous Stem Cell Transplant for Newly Diagnosed Gliomas Status COMPLETED Phase NA
NCT00253448 Stereotactic Radiosurgery and Radiation Therapy in Treating Patients With Glioblastoma Multiforme Status COMPLETED Phase PHASE2
NCT00243022 Dietary, Herbal and Alternative Medicine in Glioblastoma Multiforme Status TERMINATED Phase PHASE2
NCT00238277 Temozolomide During and After Radiation Therapy in Treating Patients Who Have Undergone Previous Surgery and Placement of Gliadel Wafers for Newly Diagnosed Glioblastoma Multiforme Status TERMINATED Phase PHASE2
NCT00238173 Acetylcysteine, Mannitol, Combination Chemotherapy, and Sodium Thiosulfate in Treating Children With Malignant Brain Tumors Status TERMINATED Phase PHASE1
NCT00227032 Erlotinib in Treating Patients With Progressive Glioblastoma Multiforme Status TERMINATED Phase PHASE1
NCT00182819 Radiation Therapy or Temozolomide in Treating Patients With Gliomas Status COMPLETED Phase PHASE3
NCT00138216 Temozolomide, Vincristine, and Irinotecan in Treating Young Patients With Refractory Solid Tumors Status COMPLETED Phase PHASE1
NCT00128700 Temozolomide and Radiation Therapy With or Without Vatalanib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Status COMPLETED Phase PHASE1/PHASE2
NCT00128635 Iodine I 131 Monoclonal Antibody TNT-1/B in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme Status COMPLETED Phase PHASE1
NCT00124657 Erlotinib and Radiation Therapy in Treating Young Patients With Newly Diagnosed Glioma Status COMPLETED Phase PHASE1/PHASE2
NCT00114140 Temozolomide and Radiation Therapy in Treating Patients With Gliomas Status COMPLETED Phase PHASE2
NCT00112619 Topotecan in Treating Young Patients With Neoplastic Meningitis Due to Leukemia, Lymphoma, or Solid Tumors Status TERMINATED Phase PHASE1
NCT00112502 Temozolomide Alone or in Combination With Thalidomide and/or Isotretinoin and/or Celecoxib in Treating Patients Who Have Undergone Radiation Therapy for Glioblastoma Multiforme Status COMPLETED Phase PHASE2
NCT00107458 Valproic Acid in Treating Young Patients With Recurrent or Refractory Solid Tumors or CNS Tumors Status COMPLETED Phase PHASE1
NCT00107237 AEE788 and Everolimus in Treating Patients With Recurrent or Relapsed Glioblastoma Multiforme Status COMPLETED Phase PHASE1/PHASE2
NCT00107185 Vaccine Therapy in Treating Young Patients Who Are Undergoing Surgery for Malignant Glioma Status COMPLETED Phase PHASE1
NCT00105560 Proton Beam Radiation Therapy in Treating Young Patients Who Have Undergone Biopsy or Surgery for Medulloblastoma or Pineoblastoma Status COMPLETED Phase NA